Observational Study on the Effect of NovoMix® 30, Levemir® or NovoRapid® (Alone or Combined) in Type 2 Diabetics Previously Treated With Anti-diabetic Medication
Condition(s):Diabetes; Diabetes Mellitus, Type 2Last Updated:January 19, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Diabetes; Diabetes Mellitus, Type 2Last Updated:January 19, 2017Completed
Condition(s):HypertensionLast Updated:July 16, 2010Completed
Condition(s):Congenital Bleeding Disorder; Haemophilia A With Inhibitors; Haemophilia B With InhibitorsLast Updated:January 11, 2017Completed
Condition(s):Pain; Bone MetastasisLast Updated:August 7, 2013Completed
Condition(s):Nasopharyngeal Neoplasms; CarcinomaLast Updated:July 30, 2015Completed
Condition(s):Afibrinogenemia, CongenitalLast Updated:November 12, 2020Completed
Condition(s):Breast NeoplasmsLast Updated:April 27, 2021Completed
Condition(s):Diabetes; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Relatives to/Carers of Patients; Healthcare ProfessionalsLast Updated:January 19, 2017Completed
Condition(s):Multiple SclerosisLast Updated:April 5, 2018Completed
Condition(s):Congenital Bleeding Disorder; Glanzmann’s DiseaseLast Updated:December 23, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.